Ligand Pharmaceuticals
LGND
#4397
Rank
A$2.87 B
Marketcap
$157.50
Share price
1.28%
Change (1 day)
61.99%
Change (1 year)

EPS for Ligand Pharmaceuticals (LGND)

EPS in 2023 (TTM): $2.37

According to Ligand Pharmaceuticals's latest financial reports the company's current EPS (TTM) is $2.35. In 2022 the company made an earnings per share (EPS) of -$2.97 a decrease over its 2021 EPS that were of $5.19.

EPS history for Ligand Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$2.37-179.84%
2022-$2.97-157.23%
2021$5.19-2571.43%
2020-$0.21-100.46%
2019$45.91353.48%
2018$10.121025%
2017$0.90-700%
2016-$0.15-100.87%
2015$17.341859.32%
2014$0.885.36%
2013$0.848.0704505322479E+18%
2012$0.0000000000-100%
2011$0.73-194.23%
2010-$0.78548.38%
2009-$0.12-98.7%
2008-$9.27-136.52%
2007$25.38-787.8%
2006-$3.69-14.58%
2005-$4.32-21.31%
2004-$5.49-55.15%
2003-$12.2481.33%
2002-$6.752.74%
2001-$6.57-45.93%
2000-$12.15-14.56%
1999-$14.22-45.52%
1998-$26.10-3.97%
1997-$27.18132.31%
1996-$11.70

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$21.22 801.27%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.54-122.93%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.25 122.98%๐Ÿ‡ฌ๐Ÿ‡ง UK
$2.73 16.03%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.79 18.47%๐Ÿ‡บ๐Ÿ‡ธ USA
$8.14 245.81%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.95 152.87%๐Ÿ‡บ๐Ÿ‡ธ USA
$7.68 226.11%๐Ÿ‡บ๐Ÿ‡ธ USA
$21.13 797.15%๐Ÿ‡บ๐Ÿ‡ธ USA